drugset / Trial / NCT00417274

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

NCT00417274 ↗

Phase 2 Completed 31 enrolled Cleveland BioLabs
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether quinacrine is effective in the treatment of Androgen-Independent Prostate Cancer.

Timeline

Start
2006-12
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinacrine Small molecule 100 mg —

Indications